Neonatal & Maternity Equipment Business — Business Valuation Multiple
EBITDA Valuation Guide · Small & Mid-Sized Businesses
Actual EBITDA multiples can vary materially based on EBITDA size, growth, recurring revenue, margins, customer concentration, owner dependence, geography and other company-specific factors.
Min
4×
Typical
6×
Max
8×
Revenue Model
Repeat
Capital Intensity
High
A typical multiple of 6× EBITDA reflects mid-market transactions in the $1–$50M revenue range.
Overview
Neonatal and maternity medical equipment businesses typically trade at 4×–8× EBITDA. Regulatory approved medical devices, NHS framework supply agreements, and recurring consumable and servicing income from an installed equipment base support premium valuations. Clinical validation requirements and NHS procurement cycle delays are the primary risk factors.
Key Value Drivers
- Regulatory approved medical devices
- NHS framework supply agreements
- Recurring consumable and service income
- Strong clinical evidence base
- Established hospital network relationships
Key Risks
- Clinical validation and regulatory approval cost
- NHS procurement cycle delays
- Reimbursement pathway complexity
- Post-market surveillance obligations
- Competition from large MedTech incumbents
Related Industries
Disclaimer: All multiples are indicative estimates only and are not formal valuations or investment advice. They should not be relied upon for financial decision-making without independent professional advice.